Jordt Raymond M — SEC Form 4 filings
SEC reporting owner CIK 1960780. 11 Form 4 filings on record with FilingPulse; latest filed 2026-02-02.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-29 to 2026-02-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Altimmune, Inc. (ALT) | Chief Business Officer | 11 | — | — | 24 |
Form 4 filings — Jordt Raymond M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-02 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 4,571 @ $3.07 | EDGAR |
| 2026-01-29 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 15,850 @ $0 · Tax withholding (F): 4,229 @ $6.18 · Option exercise (M): 15,850 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 14,600 @ $0 · Tax withholding (F): 3,855 @ $5.50 · Option exercise (M): 14,600 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 9,375 @ $0 · Tax withholding (F): 2,475 @ $3.61 · Option exercise (M): 9,375 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 1,368 @ $3.14 | EDGAR |
| 2025-02-03 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 2,614 @ $5.18 | EDGAR |
| 2025-01-28 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 14,600 @ $0 · Tax withholding (F): 3,862 @ $6.98 · Option exercise (M): 14,600 (derivative) @ $0 · Grant/award (A): 183,600 (derivative) @ $0 · Grant/award (A): 63,400 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Altimmune, Inc. (ALT) | Option exercise (M): 9,375 @ $0 · Tax withholding (F): 2,485 @ $7.21 · Option exercise (M): 9,375 (derivative) @ $0 | EDGAR |
| 2024-08-01 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 917 @ $5.41 | EDGAR |
| 2024-02-01 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 5,030 @ $2.69 | EDGAR |
| 2024-01-29 | 4 | Altimmune, Inc. (ALT) | Grant/award (A): 163,200 (derivative) @ $0 · Grant/award (A): 58,400 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1960780 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →